AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal
WSJ·2026-07-08 11:44

交易条款 - 中国生物制药将获得来自阿斯利康的2亿美元首付款[1] - 中国生物制药将有资格获得后续里程碑付款[1]

AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal - Reportify